70562007: Leuprorelin acetate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\...

\Peptide hormone\Gonadotropin releasing factor\Leuprorelin acetate

\Gonad regulating hormone agent (substance)\Leuprorelin acetate

\Hypothalamic releasing factor\Gonadotropin releasing factor\Leuprorelin acetate

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Leuprorelin acetate
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\Peptide hormone\Gonadotropin releasing factor\Leuprorelin acetate
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\Gonad regulating hormone agent (substance)\Leuprorelin acetate
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\Hypothalamic releasing factor\Gonadotropin releasing factor\Leuprorelin acetate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Peptide\Peptide hormone\Gonadotropin releasing factor\Leuprorelin acetate

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Peptide\Peptide hormone\Gonadotropin releasing factor\Leuprorelin acetate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

117207019 Leuprolide acetate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

117208012 Leuprorelin acetate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3720080013 Leuprorelin acetate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

12311000188110 leuproréline acétate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Leuprorelin acetate	Is a	Acetate	false	Inferred relationship	Some
Leuprorelin acetate	Is a	agent antinéoplasique	false	Inferred relationship	Some
Leuprorelin acetate	Is a	Antineoplastic agent (substance)	true	Inferred relationship	Some
Leuprorelin acetate	Is a	Leuprorelin (substance)	false	Inferred relationship	Some
Leuprorelin acetate	Is a	Acetate compound	false	Inferred relationship	Some
Leuprorelin acetate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Hypothalamic releasing factor (disposition)	true	Inferred relationship	Some
Leuprorelin acetate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Leuprorelin (substance)	true	Inferred relationship	Some
Leuprorelin acetate	Is a	Gonad regulating hormone agent (substance)	true	Inferred relationship	Some
Leuprorelin acetate	Is a	Gonadotropin releasing factor	true	Inferred relationship	Some
Leuprorelin acetate	Is a	Hypothalamic releasing factor	false	Inferred relationship	Some
Leuprorelin acetate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Gonad regulating hormone	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Leuprorelin acetate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Leuprorelin acetate	Inferred relationship	Some
Leuprolide acetate 3.75mg powder for injection solution + diluent	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Leuprorelin acetate	Inferred relationship	Some
Leuprolide acetate 11.25mg injection powder for injection solution + diluent	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Leuprorelin acetate	Inferred relationship	Some
Leuprolide acetate 3.75mg/vial powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Leuprorelin acetate	Inferred relationship	Some
Leuprolide acetate 7.5mg powder for injection suspension vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Leuprorelin acetate	Inferred relationship	Some
Leuprolide acetate 22.5mg powder for injection suspension vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Leuprorelin acetate	Inferred relationship	Some
Leuprolide acetate 30mg powder for injection suspension vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Leuprorelin acetate	Inferred relationship	Some
Leuprolide acetate 11.25mg powder for injection suspension vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Leuprorelin acetate	Inferred relationship	Some
Leuprolide acetate 3.75mg injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Leuprorelin acetate	Inferred relationship	Some
Leuprolide acetate 15mg powder and solvent for injection suspension vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Leuprorelin acetate	Inferred relationship	Some
Leuprolide acetate 5mg/mL injection solution 0.2mL ampule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Leuprorelin acetate	Inferred relationship	Some
Leuprolide acetate 30mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Leuprorelin acetate	Inferred relationship	Some
Leuprolide acetate 3.75mg/vial powder for injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Leuprorelin acetate	Inferred relationship	Some
Leuprolide acetate 65mg implant	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Leuprorelin acetate	Inferred relationship	Some
Leuprolide acetate 3.75mg powder for injection solution + diluent	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Leuprorelin acetate	Inferred relationship	Some
Leuprolide acetate 11.25mg injection powder for injection solution + diluent	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Leuprorelin acetate	Inferred relationship	Some
Leuprolide acetate 3.75mg/vial powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Leuprorelin acetate	Inferred relationship	Some
Leuprolide acetate 45mg powder for injection suspension vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Leuprorelin acetate	Inferred relationship	Some
Leuprolide acetate 15mg powder for injection suspension vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Leuprorelin acetate	Inferred relationship	Some
Leuprorelin acetate 11.25 mg powder for solution for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Leuprorelin acetate	Inferred relationship	Some	1
Leuprorelin acetate 11.25 mg powder for solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Leuprorelin acetate	Inferred relationship	Some	1
Leuprorelin acetate 3.75 mg powder for solution for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Leuprorelin acetate	Inferred relationship	Some	1
Leuprorelin acetate 3.75 mg powder for solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Leuprorelin acetate	Inferred relationship	Some	1
Leuprorelin acetate 7.5 mg/mL suspension for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Leuprorelin acetate	Inferred relationship	Some	1
Leuprorelin acetate 7.5 mg/mL suspension for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Leuprorelin acetate	Inferred relationship	Some	1
Leuprorelin acetate 20 mg/mL suspension for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Leuprorelin acetate	Inferred relationship	Some	1
Leuprorelin acetate 20 mg/mL suspension for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Leuprorelin acetate	Inferred relationship	Some	1
Product containing precisely leuprorelin acetate 120 milligram/1 milliliter conventional release suspension for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Leuprorelin acetate	Inferred relationship	Some	1
Product containing precisely leuprorelin acetate 120 milligram/1 milliliter conventional release suspension for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Leuprorelin acetate	Inferred relationship	Some	1
Product containing precisely leuprorelin acetate 60 milligram/1 milliliter conventional release suspension for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Leuprorelin acetate	Inferred relationship	Some	1
Product containing precisely leuprorelin acetate 60 milligram/1 milliliter conventional release suspension for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Leuprorelin acetate	Inferred relationship	Some	1
Product containing precisely leuprorelin acetate 3.75 milligram/1 syringe powder for conventional release suspension for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Leuprorelin acetate	Inferred relationship	Some	1
Product containing precisely leuprorelin acetate 3.75 milligram/1 syringe powder for conventional release suspension for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Leuprorelin acetate	Inferred relationship	Some	1
Leuprorelin acetate 7.5 mg powder for suspension for injection syringe	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Leuprorelin acetate	Inferred relationship	Some	1
Leuprorelin acetate 7.5 mg powder for suspension for injection syringe	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Leuprorelin acetate	Inferred relationship	Some	1
Product containing precisely leuprorelin acetate 45 milligram/1 syringe powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Leuprorelin acetate	Inferred relationship	Some	1
Product containing precisely leuprorelin acetate 45 milligram/1 syringe powder for conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Leuprorelin acetate	Inferred relationship	Some	1
Product containing precisely leuprorelin acetate 22.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Leuprorelin acetate	Inferred relationship	Some	1
Product containing precisely leuprorelin acetate 22.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Leuprorelin acetate	Inferred relationship	Some	1
Product containing precisely leuprorelin acetate 11.25 milligram/1 syringe powder for prolonged-release suspension for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Leuprorelin acetate	Inferred relationship	Some	1
Product containing precisely leuprorelin acetate 11.25 milligram/1 syringe powder for prolonged-release suspension for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Leuprorelin acetate	Inferred relationship	Some	1
Product containing precisely leuprorelin acetate 30 milligram/1 syringe powder for prolonged-release suspension for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Leuprorelin acetate	Inferred relationship	Some	1
Product containing precisely leuprorelin acetate 30 milligram/1 syringe powder for prolonged-release suspension for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Leuprorelin acetate	Inferred relationship	Some	1
Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Leuprorelin acetate	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
117207019	Leuprolide acetate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
117208012	Leuprorelin acetate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3720080013	Leuprorelin acetate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
12311000188110	leuproréline acétate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module